Table 2.
Association Between CSF Aβ1–42/ CSF P-Tau181P Mixture Model Classification and Diagnostic Follow-up Broken Down by Diagnosis at Baseline
Diagnosis at Baseline |
Mixture Model Classification |
Latest Follow-up Diagnosis, No. (%) |
P Value for Associationa |
|||
---|---|---|---|---|---|---|
Normal | MCI | AD | ||||
Normal | AD | 37 (91) | 3 (8) | 0 | ![]() |
.13 |
Healthy | 71 (99) | 1 (1) | 0 | |||
MCI | AD | 2 (1) | 100 (73) | 35 (26) | ![]() |
.04 |
Healthy | 3 (6) | 42 (82) | 6 (12) | |||
AD | AD | 0 | 0 | 88 (100) | ![]() |
>.99 |
Healthy | 0 | 0 | 10 (100) |
Abbreviations: AD, Alzheimer disease; CSF Aβ1–42, cerebrospinal fluid–derived β-amyloid protein 1–42; CSF P-Tau181P, cerebrospinal fluid–derived phosphorylated tau181P; MCI, mild cognitive impairment.
Fisher exact test.